The Rise of Tumor Ablation: Disrupting the Rehabilitation Industry with Technology

What is Tumor Ablation?

Tumor ablation is a minimally invasive medical procedure used to destroy abnormal tissues or tumors, such as cancerous or non-cancerous growths, without the need for surgery. It is typically performed using various energy sources, including radiofrequency, microwave, laser, or ultrasound.
During a tumor ablation procedure, a small needle or probe is inserted into the tumor under guidance of imaging techniques, such as ultrasound or CT scan. The energy source is then applied to the probe, which generates heat that destroys the cancerous cells or abnormal tissues.

The heat causes coagulation of the tissues and eventual necrosis, leading to the destruction of the tumor.

Tumor ablation is usually performed under local anesthesia, and patients can often go home the same day. It is a relatively safe and effective alternative to surgery for patients who are not good candidates for surgery or who prefer a less invasive treatment option.

Tumor ablation can be used to treat tumors in various organs, including the liver, lung, kidney, and bone. It can also be used in combination with other treatments, such as chemotherapy or radiation therapy, to improve treatment outcomes.

While tumor ablation is generally safe, it may not be suitable for all types of tumors or all patients. It is important to discuss the potential risks and benefits of the procedure with a qualified healthcare professional before undergoing the treatment.

Request Report Sample - https://www.alliedmarketresearch.com/request-sample/17626

Tumor Ablation market

The global tumor ablation market is a growing market that is driven by several factors, including the rising incidence of cancer, increasing demand for minimally invasive procedures, and advancements in technology. According to a report by MarketsandMarkets, the global tumor ablation market is projected to reach $615.4 million by 2022, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period from 2017 to 2022.

The market is segmented by technology, mode of treatment, application, and region. By technology, the market is segmented into radiofrequency ablation, microwave ablation, cryoablation, and others. By mode of treatment, the market is segmented into percutaneous, laparoscopic, and surgical ablation. By application, the market is segmented into liver cancer, lung cancer, kidney cancer, bone metastasis, and others.

North America is the largest market for tumor ablation, driven by the increasing prevalence of cancer, favorable reimbursement policies, and the presence of key market players in the region. However, the Asia Pacific region is expected to grow at the highest CAGR during the forecast period, driven by increasing awareness about cancer, improving healthcare infrastructure, and rising disposable incomes.

Some of the key players in the tumor ablation market include Medtronic plc, AngioDynamics, Inc., Boston Scientific Corporation, Mermaid Medical A/S, and NeuWave Medical, Inc. These companies are investing in research and development to launch new and innovative products in the market and to expand their presence in emerging markets.

Know More- https://www.alliedmarketresearch.com/press-release/tumor-ablation-market.html

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.